I obtained my BSc in Biology from the University of Washington in 2019. My team utilizes strategies that involve using oncolytic viruses, chimeric receptors, and altering signaling networks to enhance the efficacy of T cells against cancer. The goal is for these engineered T cells to overcome the hostile tumor microenvironment and safely improve patient outcomes. 

Back to top